Session VII: Acute Leukemia - Part I
Tracks
Plenary Hall
Saturday, October 12, 2024 |
10:00 AM - 11:10 PM |
Speaker
Prof. Hartmut Döhner
Deputy Director, Comprehensive Cancer Center
Ulm University Hospital
Incorporation of Gemtuzumab in the upfront management of AML
10:00 AM - 10:20 AM
Prof. Hartmut Döhner
Deputy Director, Comprehensive Cancer Center
Ulm University Hospital
Updates in the upfront management of FLT3 positive AML
10:20 AM - 10:40 AM
Dr. Fatima Khadadah
Senior Registrar
Kuwait Cancer Control Centre
Updates on MDS
10:40 AM - 11:00 AMSession Chair
Thuraya Al Busaidi
Consultant Hematologist
Sultan Qaboos University Hospital
Murtadha Al Khabori
Senior Consultant Hematologist
Sultan Qaboos University Hospital